SMOFlipid 20%

DRUG2 trials

Sponsors

The Hospital for Sick Children, Dr. Soetomo General Hospital

Conditions

Gastrointestinal Motility DisorderIntestinal FailureMucosal EnteropathyShort Bowel SyndromeSurgery

Phase 2

Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?

The Hospital for Sick ChildrenGastrointestinal Motility Disorder, Intestinal Failure, Mucosal Enteropathy +1

Start: 2009-01-31End: 2012-01-31Target: 24Updated: 2011-11-03

Unknown Phase

Impact of Fish Oil-enriched Lipid Emulsion on Fatty Acid and Inflammatory Response in Infants After Surgery

CompletedNCT04511299

Dr. Soetomo General HospitalSurgery

Start: 2020-04-07End: 2020-07-13Updated: 2020-08-13

Related Papers

Preventing the Progression of Intestinal Failure–Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid

Journal of Parenteral and Enteral Nutrition2016-02-02149 citations